Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer

Clinical Pharmacology and Therapeutics

Volumn 73, Issue 5, 2003, Pages 417-426

  Tegeder, Irmgard ^a   Bräutigam, Lutz ^a   Seegel, Maic ^a   Al Dam, Ahmed ^a   Turowski, Bernd ^a   Geisslinger, Gerd ^a   Kovács, Adorjám F ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; SODIUM THIOSULFATE;

ADULT; AGED; AREA UNDER THE CURVE; ARTERY CATHETERIZATION; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CELL KILLING; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG INFUSION; DRUG TUMOR LEVEL; FACE EDEMA; HUMAN; HYPERGLYCEMIA; LEUKOCYTOSIS; MICRODIALYSIS; MOUTH CANCER; NAUSEA; PAIN; PRIORITY JOURNAL; SYSTEMIC DISEASE; TUMOR CELL; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; ANTIDOTES; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; CALIBRATION; CATHETERIZATION; CISPLATIN; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MICRODIALYSIS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASMS, SQUAMOUS CELL; PLATINUM; THIOSULFATES;

EID: 0038554283     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(03)00008-0     Document Type: Article

References (34)

1. Kovács AF, Turowski B, Ghahremani MT, Loitz M. Intraarterial chemotherapy as neoadjuvant treatment of oral cancer. J Craniomaxillofac Surg 1999;27:302-7.
2. Los G, Blommaert FA, Barton R, Heath DD, den Gngelse L, et al. Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation. Cancer Chemother Pharmacol 1995;37:150-4.
3. Robbins KT, Vicario D, Seagren S, Weisman R, Pellitteri P, Kerber C, et al. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 1994;168:419-22.
4. Robbins KT, Storniolo AM, Kerber C, Seagren S, Berson A, Howell SB. Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck 1992;14:364-71.
5. Chen HS, Gross JF. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 1980;64:31-40.
6. Kerber CW, Wong WH, Howell SB, Hanchett K, Robbins KT. An organ-preserving selective arterial chemotherapy strategy for head and neck cancer. AJNR Am J Neuroradiol 1998;19:935-41.
7. Robbins KT, Storniolo AM, Kerber C, Vicario D, Seagren S, Shea M, et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol 1994;12:2113-20.
8. Montine TJ, Borch RF. Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum (II) nephrotoxicity and modulation by thiol rescue agents. Cancer Res 1988;48:6017-24.
9. Pfeifle CE, Howell SB, Felthouse RD, Woliver TB, Andrews PA, Markman M, et al. High-dose cisplatin with sodium thiosulfate protection. J Clin Oncol 1985;3:237-44.
10. Howell SB, Pfeifle CE, Wung WE, Olshen RA. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. Cancer Res 1983;43:1426-31.
11. Muldoon LL, Pagel MA, Kroll RA, Brummett RE, Doolittle ND, Zuhowski EG, et al. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin Cancer Res 2000;6:309-15.
12. Welters MJ, Fichtinger-Schepman AM, Baan RA, Jacobs-Bergmans AJ, Kegel A, van der Vijgh WJ, et al. Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo. Br J Cancer 1999;79:82-8.
13. Farah N, Dresner HS, Searles KJ, Winiarsky R, Moosikasuwan M, Cajigas A, et al. Cisplatin DNA adduct detection and depurination measured by 32P DNA radiolabeling and two-dimensional thin-layer chromatography: a time and concentration study. Cancer Invest 2000;18:314-26.
14. Schellens JH, Ma J, Planting AS, van den Burg ME, van Meerten E, de Boer-Dennert M, et al. Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours. Br J Cancer 1996;73:1569-75.
15. Robbins KT, Kumar P, Regine WF, Wong FS, Weir AB 3d, Flick P, et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys 1997;38:263-71.
16. Robbins KT, Kumar P, Wong FS, Hartsell WF, Flick P, Palmer P, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck 2000;22:687-93.
17. Kovács AF, Obitz P, Wagner M. Monocomponent chemoembolization in oral and oropharyngeal cancer using an aqueous crystal suspension of cisplatin. Br J Cancer 2002;86:196-202.
18. Kovács AF, Turowski B. Chemoembolization of oral and oropharyngeal cancer using a high-dose cisplatin crystal suspension and degradable starch microspheres. Oral Oncol 2002;38:87-95.
19. Ungerstedt U. Microdialysis - principles and applications for studies in animals and man. J Intern Med 1991;230:365-73.
20. Sobin LH, Wittekind C. UICC: TNM classification of malignant tumours. New York: John Wiley; 1997.
21. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
22. Tegeder I, Muth-Selbach U, Lötsch J, Rüsing G, Oelkers R, Brune K, et al. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther 1999;65:357-68.
23. Augey V, Cociglio M, Galtier M, Yearoo R, Pinsani V, Bressolle F. High-performance liquid chromatographic determination of cis-dichlorodiammineplatinum (II) in plasma ultrafiltrate. J Pharm Biomed Anal 1995;13:1173-8.
24. Goel R, Andrews PA, Pfeifle CE, Abramson IS, Kirmani S, Howell SB. Comparison of the pharmacokinetics of ultrafilterable cisplatin species detectable by derivatization with diethyldithiocarbamate or atomic absorption spectroscopy. Eur J Cancer 1990;26:21-7.
25. Shea M, Howell S. High-performance liquid chromatographic measurement of exogenous thiosulfate in urine and plasma. Anal Biochem 1984;140:589-94.
26. Markman M, D'Acquisto R, Iannotti N, Kris M, Hakes T, Bajorin D, et al. Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate. J Cancer Res Clin Oncol 1991;117:151-5.
27. Gouyette A, Apchin A, Foka M, Richard JM. Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patients. Eur J Cancer Clin Oncol 1986;22:257-63.
28. Müller M, Mader RM, Steiner B, Steger GG, Jansen B, Gnant M, et al. 5-Fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients. Cancer Res 1997;57:2598-601.
29. Galmarini FC, Galmarini CM, Sarchi MI, Abulafia J, Galmarini D. Heterogeneous distribution of tumor blood supply affects the response to chemotherapy in patients with head and neck cancer. Microcirculation 2000;7:405-10.
30. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987;47:3039-51.
31. Presant CA, Wolf W, Waluch V, Wiseman C, Kennedy P, Blayney D, et al. Association of intratumoral pharmacokinetics of fluorouracil with clinical response. Lancet 1994;343:1184-7.
32. Abe R, Akiyoshi T, Tsuji H, Baba T. Protection of antiproliferative effect of cis-diamminedichloroplatinum (II) by sodium thiosulfate. Cancer Chemother Pharmacol 1986;18:98-100.
33. Abe R, Akiyoshi T, Baba T. Inactivation of cis-diamminedichloroplatinum (II) in blood by sodium thiosulfate. Oncology 1990;47:65-9.
34. Kovács AF, Cinatl J. In vitro cytotoxic dose-relation of cisplatin and sodium thiosulfate in human tongue and esophageal squamous carcinoma cell lines. J Craniomaxillofac Surg 2002;30:112-20.